PT - JOURNAL ARTICLE AU - Akeret, Kevin AU - Buzzi, Raphael M. AU - Schaer, Christian A. AU - Thomson, Bart R. AU - Vallelian, Florence AU - Wang, Sophie AU - Willms, Jan AU - Sebök, Martina AU - Held, Ulrike AU - Deuel, Jeremy W. AU - Humar, Rok AU - Regli, Luca AU - Keller, Emanuela AU - Hugelshofer, Michael AU - Schaer, Dominik J. TI - Cerebrospinal fluid hemoglobin drives subarachnoid hemorrhage-related secondary brain injury AID - 10.1101/2021.02.13.21251469 DP - 2021 Jan 01 TA - medRxiv PG - 2021.02.13.21251469 4099 - http://medrxiv.org/content/early/2021/02/16/2021.02.13.21251469.short 4100 - http://medrxiv.org/content/early/2021/02/16/2021.02.13.21251469.full AB - Secondary brain injury after aneurysmal subarachnoid hemorrhage (SAH-SBI) is a significant contributor to poor outcomes in patients after rupture of an intracranial aneurysm. The lack of diagnostic biomarkers and novel drug targets represent an unmet need. Prior experimental evidence has suggested cell-free hemoglobin in the cerebrospinal fluid (CSF-Hb) as a pathophysiological driver of SAH-SBI. The aim of this study was to investigate the clinical and pathophysiological association between CSF-Hb and SAH-SBI. We prospectively enrolled 47 consecutive patients and collected daily CSF samples within 14 days after aneurysm rupture. There was very strong evidence for a positive association between CSF-Hb and SAH-SBI. The diagnostic accuracy of CSF-Hb for SAH-SBI markedly exceeded that of established methods (area under the curve: 0.89 [0.85-0.92]). Temporal LC-MS/MS CSF proteomics demonstrated that erythrolysis accompanied by an adaptive macrophage response are the two dominant biological processes occurring in the CSF space after aneurysm rupture. To further investigate the pathophysiology between CSF-Hb and SAH-SBI, we explored the vasoconstrictive and lipid peroxidation activities of Hb ex-vivo. These experiments revealed critical inflection points overlapping CSF-Hb concentration thresholds in patients with SAH-SBI. Selective Hb depletion and in-solution neutralization by the Hb-scavenger haptoglobin or the heme-scavenger hemopexin efficiently attenuated the vasoconstrictive and lipid peroxidation activities of CSF-Hb in patient CSF. Collectively, the clinical association between high CSF-Hb levels and SAH-SBI, the underlying pathophysiological rationale, and the favorable effects of haptoglobin and hemopexin in ex-vivo experiments position CSF-Hb as a highly attractive biomarker and potential drug target.Competing Interest StatementDJS, CAS and MH are inventors on a provisional patent application on the use of haptoglobin in aSAH. All the other authors declare that they have no competing financial interests.Funding StatementThis study was supported by the Swiss National Science Foundation (310030_197823, and MD-PhD scholarship 4221-06-2017 to RMB), Innosuisse (36361 IP-LS), the Uniscientia Foundation, and the Forschungskredit of the University of Zurich (grant No. 20-025 to RMB).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The approval for this study was granted by the ethical review board of the Canton of Zurich, Switzerland (Head: Prof. Dr. med. Erich W. Russi) in July 2016 (KEK ZH 2016-00439).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe authors confirm that the data supporting the findings of this study are available within the article and its Supplementary Materials. In addition, all anonymized datasets used in this study along with the statistical code are provided in the Supplementary Materials (for an overview, see Supplementary Table 3). The use of dynamic reporting guarantees full reproducibility of the results given data and code.